PL2170512T3 - Regeneracja wymiennika anionów obładowanego heksachlorocynianem - Google Patents

Regeneracja wymiennika anionów obładowanego heksachlorocynianem

Info

Publication number
PL2170512T3
PL2170512T3 PL08773912T PL08773912T PL2170512T3 PL 2170512 T3 PL2170512 T3 PL 2170512T3 PL 08773912 T PL08773912 T PL 08773912T PL 08773912 T PL08773912 T PL 08773912T PL 2170512 T3 PL2170512 T3 PL 2170512T3
Authority
PL
Poland
Prior art keywords
anion exchanger
hexachlorostannate
regeneration
loaded anion
loaded
Prior art date
Application number
PL08773912T
Other languages
English (en)
Inventor
Torsten Erwe
Knud Werner
Dirk Weissenberg
Original Assignee
Bayer Materialscience Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Materialscience Ag filed Critical Bayer Materialscience Ag
Publication of PL2170512T3 publication Critical patent/PL2170512T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B7/00—Halogens; Halogen acids
    • C01B7/01—Chlorine; Hydrogen chloride
    • C01B7/07—Purification ; Separation
    • C01B7/0706—Purification ; Separation of hydrogen chloride
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
    • B01J49/50—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents
    • B01J49/57—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents for anionic exchangers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
PL08773912T 2007-07-19 2008-07-08 Regeneracja wymiennika anionów obładowanego heksachlorocynianem PL2170512T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007033524A DE102007033524A1 (de) 2007-07-19 2007-07-19 Regeneration eines mit Hexachlorostannat beladenen Anionenaustauschers
EP08773912A EP2170512B1 (de) 2007-07-19 2008-07-08 Regeneration eines mit hexachlorostannat beladenen anionenaustauschers
PCT/EP2008/005544 WO2009010209A1 (de) 2007-07-19 2008-07-08 Regeneration eines mit hexachlorostannat beladenen anionenaustauschers

Publications (1)

Publication Number Publication Date
PL2170512T3 true PL2170512T3 (pl) 2012-07-31

Family

ID=39789628

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08773912T PL2170512T3 (pl) 2007-07-19 2008-07-08 Regeneracja wymiennika anionów obładowanego heksachlorocynianem

Country Status (11)

Country Link
US (1) US8337703B2 (pl)
EP (1) EP2170512B1 (pl)
JP (1) JP2010533574A (pl)
KR (1) KR20100034011A (pl)
CN (1) CN101754810B (pl)
AT (1) ATE544517T1 (pl)
DE (1) DE102007033524A1 (pl)
ES (1) ES2380992T3 (pl)
PL (1) PL2170512T3 (pl)
PT (1) PT2170512E (pl)
WO (1) WO2009010209A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8242156B2 (en) 2009-02-17 2012-08-14 Enanta Pharmaceuticals, Inc. Linked dibenzimidazole derivatives
US8673954B2 (en) 2009-02-27 2014-03-18 Enanta Pharmaceuticals, Inc. Benzimidazole derivatives
US9765087B2 (en) 2009-02-27 2017-09-19 Enanta Pharmaceuticals, Inc. Benzimidazole derivatives
EP2435424B1 (en) 2009-05-29 2015-01-21 Merck Sharp & Dohme Corp. Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
EP2503881B1 (en) 2009-11-25 2015-05-13 Merck Sharp & Dohme Corp. Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases
AU2010341537A1 (en) 2009-12-22 2012-08-09 Merck Sharp & Dohme Corp. Fused Tricyclic Compounds and methods of use thereof for the treatment of viral diseases
JP2013522202A (ja) 2010-03-09 2013-06-13 メルク・シャープ・エンド・ドーム・コーポレイション 縮合三環式シリル化合物およびウイルス疾患の治療のためのその使用方法
WO2012018534A2 (en) 2010-07-26 2012-02-09 Schering Corporation Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
WO2012050848A1 (en) 2010-09-29 2012-04-19 Schering Corporation Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
CN103687489A (zh) 2011-05-18 2014-03-26 埃南塔制药公司 制备5-氮杂螺[2.4]庚烷-6-甲酸及其衍生物的方法
US20140378416A1 (en) 2011-09-14 2014-12-25 Michael P. Dwyer Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
US10167298B2 (en) 2013-10-30 2019-01-01 Merck Sharp & Dohme Corp. Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof
WO2015089810A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3252920A (en) * 1960-10-06 1966-05-24 Kerr Mc Gee Oil Ind Inc Rejuvenation of poisoned ion exchange resins
US3531401A (en) * 1968-01-23 1970-09-29 Crane Co Method of regenerating ion exchangers
DE19948206A1 (de) * 1999-10-07 2001-04-12 Merck Patent Gmbh Verfahren zur Herstellung hochreiner Salzsäure
CN1446755A (zh) * 2003-04-10 2003-10-08 清华大学 弱碱性阴离子交换树脂吸附重金属方法

Also Published As

Publication number Publication date
US20090020478A1 (en) 2009-01-22
KR20100034011A (ko) 2010-03-31
PT2170512E (pt) 2012-04-26
DE102007033524A1 (de) 2009-01-22
ES2380992T3 (es) 2012-05-22
EP2170512A1 (de) 2010-04-07
EP2170512B1 (de) 2012-02-08
CN101754810A (zh) 2010-06-23
CN101754810B (zh) 2012-11-07
WO2009010209A1 (de) 2009-01-22
JP2010533574A (ja) 2010-10-28
US8337703B2 (en) 2012-12-25
ATE544517T1 (de) 2012-02-15

Similar Documents

Publication Publication Date Title
PL2170512T3 (pl) Regeneracja wymiennika anionów obładowanego heksachlorocynianem
WO2008019871A3 (de) Neue salze des wirkstoffs rasagilin
MX2009013546A (es) Composicion acuosa que contiene una sal, proceso de fabricacion y su uso.
WO2007141274A3 (en) Human binding molecules having killing activity against staphylococci and uses thereof
MX2009012786A (es) Purificacion de inmunoglobulina.
EP3272337A3 (en) Tablets
MX2010003264A (es) Derivados de bencimidazol e indol sustituidos por oxadiazol y oxazol como inhibidores de dgat1.
PL1999160T3 (pl) Akrylowany kwas hialuronowy
WO2016149501A3 (en) Modified therapeutic agents and compositions thereof
IL206453A0 (en) 3-substituted-4-oxo-3,4-dihydro-imidazo-[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amides and their use
UA100394C2 (en) Lipoic acid pellet composition
MX2016008283A (es) Analogos de bicalutamida o (s)-bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acumulo lisosomal o glucogenosis.
WO2009100262A3 (en) Oral care methods and systems
JP2011518992A5 (pl)
PT2234595E (pt) Processo para redução da tendência de um sal de glicopirrónio para se agregar durante a armazenagem
TW200716138A (en) Stable active compound complex of salts of O-acetylsalicylic acid with basic amino acids and glycine
DE602006013198D1 (de) Werkzeugmaschinenkartusche
TN2012000337A1 (en) Mixtures of alkali polysulfides
ZA201003655B (en) Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same
TW200640724A (en) Display for a vehicle
WO2009040267A3 (de) Klimatisierung einer fahrzeugbatterie
WO2008114415A1 (ja) マルチプロセッシングシステム
GR1007399B (el) Διαταξη δολωματος
CL2009001888A1 (es) Formula nutricional que tiene un ph en el estado liquido de 4,8 a 5,2, que comprende 1 a 1,2% de acido lactico y entre 0,9 a 1,4% de una sal de acido lactico, seleccionada de lactato de sodio, de potasio o de calcio.
TW200640446A (en) Prophylactic anti-stress agent